Physician profile
Gregory Fox
NPI 1669439592
$2,358.12
in general payments reported to CMS, 2019-2025
22 companies · $15.10 in 2025
The $15.10 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $180 · 2021: $224 · 2022: $617 · 2023: $552 · 2024: $599 · 2025: $15.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $600.10 | 2020-2024 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $218.11 | 2019-2024 | Jardiance, Mounjaro, Emgality |
| Janssen Pharmaceuticals, INC | $167.44 | 2019-2024 | Xarelto |
| Amgen INC. | $153.06 | 2022-2024 | Repatha, Otezla, Krystexxa |
| Novo Nordisk INC | $126.58 | 2022-2023 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $115.71 | 2019-2023 | |
| Glaxosmithkline, LLC. | $96.23 | 2020-2024 | Arexvy, Shingrix |
| Intuitive Surgical, INC. | $95.42 | 2022 | |
| Amarin Pharma, INC. | $92.63 | 2021-2022 | |
| Horizon Therapeutics Plc | $88.77 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $86.97 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.86 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.34 | 2022-2024 | |
| Abbvie INC. | $65.36 | 2021-2023 | |
| Phathom Pharmaceuticals, INC. | $62.43 | 2024 | Voquezna |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $50.17 | 2021-2023 | Immunocap |
| Abbott Laboratories | $49.02 | 2021-2023 | Freestyle Libre 2 |
| Exact Sciences Corporation | $45.96 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $35.16 | 2024-2025 | |
| Medtronic, INC. | $30.42 | 2024 | Intellis Adaptivestim |
| Dexcom, INC. | $15.88 | 2024 | Dexcom G6 Transmitter |
| Myovant Sciences INC. | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.